申请人:Josien Hubert B.
公开号:US20100087425A1
公开(公告)日:2010-04-08
This invention discloses novel gamma secretase inhibitors of the formula:
wherein:
L is —O—, —N(R
6
)—, —S—, —S(O)—, or —S(O
2
)—;
R
1
is selected from the group consisting of aryl and heteroaryl;
R
2
is selected from the group consisting of alkyl, —C(O)—Y, —X—C(O)—Y, -alkylene-X—C(O)—Y, -alkylene-C(O)—Y, -alkylene-cycloalkylene-X—C(O)—Y, -alkylene-cycloalkylene-C(O)—Y, -cycloalkylene-alkylene-X—C(O)—Y, -cycloalkylene-alkylene-C(O)—Y, -cycloalkylene-X—C(O)—Y, -cycloalkylene-C(O)—Y, -alkylene-cycloalkylene-alkylene-X—C(O)—Y, -alkylene-cycloalkylene-alkylene-C(O)—Y, aryl, and heteroaryl;
R
3
is selected from the group consisting of aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, arylheterocycloalkyl, and alkoxyalkyl;
each R
4
and R
5
is independently selected from the group consisting of H and alkyl; and
Y is selected from the group consisting of —NR
8
R
9
, —N(R
6
)—(CH
2
)
b
—NR
8
R
9
, aryl, heteroaryl, alkyl, cycloalkyl, arylalkyl, arylcycloalkyl, heteroarylalkyl, heteroarylcycloalkyl, and aryl heterocycloalkyl; or
Y is selected from the group consisting of:
One or more compounds of formula I, or formulations comprising such compounds, may be useful, e.g. in treating Alzheimer's Disease.